Category

Pharmacoeconomics

Home > Papers-Magazines > Pharmacoeconomics

Buti M, Oyagüez I, Lozano V, Casado MA

 

 

 

Cost-effectiveness of first-line oral antiviral therapies for chronic hepatitis B: A systematic review
Pharmacoeconomics. 2013;31(1):63-75

Buti M, Casado MA, Fosbrook L, Esteban R

 

 

 

Financial impact of two different ways of evaluating early virological response to peginterferon alfa-2b plus ribavirin therapy in genotype 1 naïve patients with chronic hepatitis C
Pharmacoeconomics. 2005;23:1043-55